Treatment effects of dapagliflozin in patients with aortic stenosis undergoing transcatheter aortic valve implantation across left ventricular ejection fraction
Published in Eur J Heart Fail, 2026
Top-decile (D1) journal.
Recommended citation: Raposeiras Roubín S, Gonzalez-Manzanares R , Amat-Santos I, Melendo Viu M, Dobarro D, López Otero D, Nombela Franco L, Gheorge L, Sanz-Sánchez J, Baladrón Zorita C, Ojeda S, Iñiguez Romo A, Muñoz García AJ, Vilalta V, Veiga Fernández G, Córdoba Soriano JG, Regueiro A, Sandín Rollán M, Flores Ríos X, Uribarri A, Martín Reyes R, Romaguera R, Avanzas P, García Blas S, Franco-Peláez JA, Martín Moreiras J, Gonzalez Juanatey JR, Tirado G, Calle G, Díez JL, Santos-Martínez S, González Ferreiro R, Muñoz García E, Carrillo Suarez X, Sanmartín X, Gonzalo N, Gutierrez Barri A, Asmarats L, Díaz Del Hoyo F, Camacho Freire S, Yanes G, Astorga Burgo JC, Molina Navarro E, Caballero Borrego J, González Bermúdez I, Fuster V, Ibáñez B. Treatment effects of dapagliflozin in patients with aortic stenosis undergoing transcatheter aortic valve implantation across left ventricular ejection fraction. Eur J Heart Fail. 2026 Aug 27. doi: 10.1093/ejhf/xuag242. Epub ahead of print. PMID: 42655906.
Download Paper